These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20198983)

  • 1. [Hexosoaminidase gene expression in cholesteatoma in adults].
    Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
    Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pirymethamine influence on hexosoaminidase gene expression in synovial cell culture--preliminary report].
    Olszewski S; Rutkowska J; Popko J; Dabrowska K; Bielawski T; Olszewska E
    Pol Merkur Lekarski; 2010 Feb; 28(164):112-6. PubMed ID: 20369738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue.
    Olszewska E; Olszewski S; Borzym-Kluczyk M; Zwierz K
    Acta Biochim Pol; 2007; 54(2):365-70. PubMed ID: 17502924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteatoma-associated pathogenicity: potential role of lysosomal exoglycosidases.
    Olszewska E; Jakimowicz-Rudy J; Knas M; Chilimoniuk M; Pietruski JK; Sieskiewicz A
    Otol Neurotol; 2012 Jun; 33(4):596-603. PubMed ID: 22588235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of beta-defensins in human middle ear cholesteatoma.
    Park K; Moon SK; Choung YH; Choi HS
    Acta Otolaryngol; 2003 Jan; 123(2):236-40. PubMed ID: 12701748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of placenta growth factor in human middle ear cholesteatoma.
    Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
    Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
    Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
    Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
    Park M; Lee B; Lee J
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
    Chang CS; Jun BH; Song KY; Kim IG
    J Korean Med Sci; 1999 Dec; 14(6):665-70. PubMed ID: 10642946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
    Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
    Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
    Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
    Schmidt M; Schler G; Gruensfelder P; Hoppe F
    Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.